Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Most transcluded pages

From GxPlex

Jump to: navigation, search

Showing below up to 50 results in range #101 to #150.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Document:DEU StrlSchG - Strahlenschutzgesetz 03-Jan-2022 (used on 1 page)
  2. Document:DEU SGB V - Sozialgesetzbuch FĂĽnftes Buch 20-Dez-1988 (used on 1 page)
  3. Document:FRA SI RIPH 2G - Website 16-May-2025 (used on 1 page)
  4. Document:FRA AEC-DM-DMDIV DOC006 v04 AAP RDM Partie II Modalités pratiques 16-May-2025 (used on 1 page)
  5. Document:FRA AEC DOC010 V.04 01-Jun-2018 (used on 1 page)
  6. Document:GBR NIHR - National Institute for Health and Care Research 28-Jan-2025 (used on 1 page)
  7. Document:N.A. SPIRIT 2013 - Chan et al. 2013 (used on 1 page)
  8. Document:EU ENCePP - Guide on Methodological Standards in Pharmacoepidemiology Revision 11 (2023) (used on 1 page)
  9. Document:N.A. Article from Mora et al. 2023 (used on 1 page)
  10. Document:EU EMA/431265/2016 Annex I – to guidance for the conduct of good clinical practice inspections – investigator site 06-Sep-2017 (used on 1 page)
  11. Document:EU EMA/INS/GCP/143492/2022 - ANNEX I TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE CHMP: INVESTIGATOR SITE 2022 (used on 1 page)
  12. Document:GBR Medicines and Medical Devices Act 2021 21-Feb-2021 (used on 1 page)
  13. Document:ICH ICH E21 Concept paper 2023 (used on 1 page)
  14. Document:ICH ICH E7 Guideline 1993 (used on 1 page)
  15. Document:USA FDA INFORMATION SHEET - Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators Jan-1998 (used on 1 page)
  16. Document:GBR Guidance - Good clinical practice for clinical trials 16-Oct-2015 (used on 1 page)
  17. Document:USA FDA Information - Observations and citations 20-Mar-2024 (used on 1 page)
  18. Document:WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report (used on 1 page)
  19. Document:EU Eudralex - volume 4 GMP Guidelines Chapter 4 Jan-2011 (used on 1 page)
  20. Document:USA FDA Guidance for Industry - Computerized Systems Used in Clinical Trials 13-Apr-2015 (used on 1 page)
  21. Document:USA FDA Guidance for Industry - Computerized Systems Used in Clinical Investigations May-2007 (used on 1 page)
  22. Document:USA FDA - HUMAN DRUG CGMP NOTES Volume 8, Number 3 (used on 1 page)
  23. Document:EU Eudralex - volume 4 GMP Guidelines Annex 11 Jan-2011 (used on 1 page)
  24. Document:GBR The Electronic Identification and Trust Services for Electronic Transactions (Amendment etc.) (EU Exit) Regulations 2019 23-Jan-2019 (used on 1 page)
  25. Document:DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4 04-Feb-2021 (used on 1 page)
  26. Document:AUT FAQ - COVID-19 Studien 15-Mar-2021 (used on 1 page)
  27. Document:FRA Bonnes pratiques - CONTRÔLE QUALITÉ À DISTANCE DES ESSAIS CLINIQUES (CNIL) 16-May-2024 (used on 1 page)
  28. Document:GBR Making changes to a research study to manage the impact of COVID-19 12-Oct-2021 (used on 1 page)
  29. Document:GBR Guidance Managing clinical trials during Coronavirus (COVID-19) 16-Nov-.2021 (used on 1 page)
  30. Document:USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 (used on 1 page)
  31. Document:IMDRF IMDRF – Guidelines - (used on 1 page)
  32. Document:EU INS/GCP/46309/2012 - Classification and analysis of the GCP inspection findings of GCP inspections conducted at the request of the CHMP 2012 (used on 1 page)
  33. Document:USA CTCAE - Common Terminology Criteria for Adverse Events v5.0 (2017) (used on 1 page)
  34. Document:ICH ICH E19 Guideline 2022 (used on 1 page)
  35. Document:DEU MPAMIV - Medizinprodukte-Anwendermelde- und Informationsverordnung 21-Apr-2021 (used on 1 page)
  36. Document:ICH ICH E2F Guideline 2010 (used on 1 page)
  37. Document:AUT MPG – Medizinproduktegesetz 26-May-2022 (used on 1 page)
  38. Document:FRA SURV VIG DOC118 V01 REC-Avis aux promoteurs -Partie V 16-May-2025 (used on 1 page)
  39. Document:EU EMEA/CHMP/313666/2005 - GUIDELINE ON THE EXPOSURE TO MEDICINAL PRODUCTS DURING PREGNANCY: NEED FOR POST-AUTHORISATION DATA 14-Nov-2005 (used on 1 page)
  40. Document:DEU AMWHV – Arzneimittel- und Wirkstoffherstellungs-verordnung 09-Aug-2019 (used on 1 page)
  41. Document:DEU BGB - BĂĽrgerliches Gesetzbuch 22-Dec-2023 (used on 1 page)
  42. Document:DEU Bundestag - Sachstand zur Aufbewahrung von Patientenakten in der ambulanten Praxis Fristen und Form 01-Mar-2021 (used on 1 page)
  43. Document:AUT Ă„rztegesetz 08-Mar-2023 (used on 1 page)
  44. Document:GBR NHS: Records Management Code of Practice 07-Aug-2023 (used on 1 page)
  45. Document:AUT Question - BASG 11-Feb-2025 (used on 1 page)
  46. Document:ICH ICH E3 Guideline 1995 (used on 1 page)
  47. Document:N.A. (STROBE)statement: guidelines for reporting observational studies Apr-2008 (used on 1 page)
  48. Document:GBR HRA - Ending your project 28-Jan-2025 (used on 1 page)
  49. Document:DEU Deutsches Ă„rzteblatt 45849 (used on 1 page)
  50. Document:EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838 (used on 1 page)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://gxplex.org/index.php?title=Special:MostTranscludedPages"